OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity
Mostafa M. Elbadawi, Wagdy M. Eldehna, Wenjie Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 215, pp. 113261-113261
Open Access | Times Cited: 39

Showing 26-50 of 39 citing articles:

Novel NO-TZDs and trimethoxychalcone-based DHPMs: design, synthesis, and biological evaluation as potential VEGFR-2 inhibitors
Mater H. Mahnashi, Mohammed H Nahari, Hassan H. Almasoudi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 1

New 5,6,7,8‐Tetrahydro‐isoquinolines Bearing 2‐Nitrophenyl Group Targeting RET Enzyme: Synthesis, Anticancer Activity, Apoptotic Induction and Cell Cycle Arrest
Abdelreheem Abdelfatah Saddik, Etify A. Bakhite, Reda Hassanien, et al.
Chemistry & Biodiversity (2024)
Closed Access | Times Cited: 1

Design, synthesis and anti-hepatocellular carcinoma activity of 3-arylisoquinoline alkaloids
Xuemei Deng, Tian Luo, Li Zhao, et al.
European Journal of Medicinal Chemistry (2021) Vol. 228, pp. 113985-113985
Closed Access | Times Cited: 12

Camptothecin structure simplification elaborated new imidazo[2,1-b]quinazoline derivative as a human topoisomerase I inhibitor with efficacy against bone cancer cells and colon adenocarcinoma
Ahmed I. Khodair, Salwa M. El‐Hallouty, Brittnee Cagle-White, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116049-116049
Closed Access | Times Cited: 4

Design, synthesis, and molecular docking study of some 2-((7-chloroquinolin-4-yl) amino) benzohydrazide Schiff bases as potential Eg5 inhibitory agents
Rohini S. Kavalapure, Shankar G. Alegaon, Venkatasubramanian Ulaganathan, et al.
Bioorganic Chemistry (2021) Vol. 116, pp. 105381-105381
Closed Access | Times Cited: 9

Design, synthesis and in vitro cytotoxic evaluation of β-carboline tethered quinoline-4-carboxamide conjugates as DNA-interactive Topo II inhibitors
Jay Prakash Soni, Priyanka Devi, Sowjanya Chemitikanti, et al.
Journal of Molecular Structure (2023) Vol. 1291, pp. 136001-136001
Closed Access | Times Cited: 3

Accessing 2‐Aryl Quinolines via Acceptorless Dehydrogenation and Transfer Hydrogenation Under Base and Solvent‐Free Reaction Conditions
M. Vageesh, P. Hima, R. Prasanna, et al.
ChemistrySelect (2023) Vol. 8, Iss. 45
Closed Access | Times Cited: 2

AN OVERVIEW OF QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS
Mostafa MA Aref, Abeer A. Mohamed, Mohammed A. Dahab, et al.
˜Al-œAzhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences (2023) Vol. 68, Iss. 2, pp. 130-158
Open Access | Times Cited: 2

QSAR Based Drug Repurposing: A New Paradigm in Breast Cancer Research
Rajaram Mohapatra, Pratikeswar Panda, Sudhansu Sekhar Rout
Indian Journal of Pharmaceutical Education and Research (2024) Vol. 58, Iss. 3, pp. 695-708
Open Access

Design and synthesis of Aza-boeravinone derivatives as potential novel topoisomerase I inhibitors
Yong Zhou, Yin-Peng Bai, Mi Zhang, et al.
Bioorganic Chemistry (2022) Vol. 122, pp. 105747-105747
Closed Access | Times Cited: 3

Synthesis and biological evaluation of novel thiazolo[4,5-d]pyrimidin-7(6H)-ones as topoisomerase I inhibitors
Laichun Luo, Qiang Wang, Yuanhang Xiang, et al.
Chemistry of Heterocyclic Compounds (2021) Vol. 57, Iss. 12, pp. 1220-1229
Closed Access | Times Cited: 1

Anticancer Activity of Quinoline Derivatives; An Overview
G Amrithanjali, Gisna Shaji, Swathykrishna C.S, et al.
International Journal of Pharmaceutical Sciences Review and Research (2022), pp. 127-135
Open Access

Previous Page - Page 2

Scroll to top